APPLIED DNA SCIENCES INC's ticker is APDN and the CUSIP is 03815U201. A total of 42 filers reported holding APPLIED DNA SCIENCES INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $20,000 | -73.0% | 50,000 | 0.0% | 0.02% | -64.3% |
Q3 2018 | $74,000 | +17.5% | 50,000 | 0.0% | 0.06% | +16.7% |
Q2 2018 | $63,000 | -12.5% | 50,000 | 0.0% | 0.05% | -15.8% |
Q1 2018 | $72,000 | -8.9% | 50,000 | 0.0% | 0.06% | -8.1% |
Q4 2017 | $79,000 | -44.8% | 50,000 | 0.0% | 0.06% | -44.1% |
Q3 2017 | $143,000 | +62.5% | 50,000 | 0.0% | 0.11% | +60.9% |
Q2 2017 | $88,000 | +7.3% | 50,000 | 0.0% | 0.07% | +6.2% |
Q1 2017 | $82,000 | -67.8% | 50,000 | -63.8% | 0.06% | -69.2% |
Q4 2016 | $255,000 | -53.6% | 138,000 | -23.3% | 0.21% | -49.0% |
Q3 2016 | $549,000 | +13.4% | 180,000 | +20.0% | 0.41% | +4.8% |
Q2 2016 | $484,000 | +0.4% | 150,000 | +7.1% | 0.40% | -6.6% |
Q1 2016 | $482,000 | +172.3% | 140,000 | +156.4% | 0.42% | +182.0% |
Q4 2015 | $177,000 | -52.9% | 54,600 | -25.6% | 0.15% | -51.1% |
Q3 2015 | $376,000 | +461.2% | 73,400 | +241.4% | 0.31% | +553.2% |
Q2 2015 | $67,000 | – | 21,500 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Benchmark Capital Advisors | 180,000 | $549,000 | 0.41% |
CHASE INVESTMENT COUNSEL CORP | 77,563 | $236,000 | 0.10% |
Crosspoint Capital Strategies, LLC | 19,321 | $59,000 | 0.08% |
DUMONT & BLAKE INVESTMENT ADVISORS LLC | 20,921 | $64,000 | 0.03% |
REILLY FINANCIAL ADVISORS, LLC | 50,000 | $153,000 | 0.03% |
Onex Canada Asset Management Inc. | 20,000 | $60,000 | 0.01% |
WILLIAMS JONES & ASSOCIATES LLC | 48,050 | $147,000 | 0.00% |
D. SCOTT NEAL, INC. | 384 | $1,000 | 0.00% |
OPPENHEIMER & CO INC | 13,527 | $41,000 | 0.00% |
Creative Planning | 56,234 | $172,000 | 0.00% |